Skip to content
General News, Medical Health Aged Care

We need to talk about metastatic breast cancer – BCNA’s new media guide

Breast Cancer Network Australia 2 mins read

6/06/2024

Breast Cancer Network Australia (BCNA) – Australia’s leading voice for people affected by breast cancer – has released a media guide on how to talk about metastatic breast cancer. 

BCNA’s Director of Policy, Advocacy and Support Services Vicki Durston said she hoped the guide would help journalists, among others, when covering stories about metastatic breast cancer, and breast cancer more generally. 

“Increasingly, metastatic breast cancer is making the news,” Ms Durston said.  

“This is important as increased awareness and understanding of the different stages of breast cancer will help drive better treatment and care. 

“However, we hear from our members that inadvertently or unconsciously, journalists can use language that offends, misrepresents, or completely ignores the realities of living with metastatic breast cancer.  

“Finding the right language when reporting on metastatic breast cancer can be challenging, but it is so important.” 

The guide includes terms to avoid, language preferences, and facts and figures about metastatic breast cancer. 

Metastatic breast cancer is when breast cancer has spread beyond the breast to other parts of the body, most often the bones, lungs, liver or brain. It is treatable but not currently curable and is a life-limiting disease. 

Metastatic is different to other stages of breast cancer, such as early breast cancer (stages I-III) or ductal carcinoma in situ (DCIS). It is the only breast cancer that people die from. 

We don’t know how many people in Australia are living with metastatic breast cancer, however the latest modelling suggests it to be at least 15,000 people.  

The Reporting Metastatic Breast Cancer Media Guide was developed in consultation with members of BCNA’s Metastatic Breast Cancer Lived Experience Reference Group.  

Mieka, a member of BCNA’s Metastatic Breast Cancer Lived Experience Reference Group, said “it is critical we raise awareness of metastatic breast cancer, hear directly from people with metastatic breast cancer, and work urgently to improve the lives of people living with metastatic breast cancer and prevent deaths from breast cancer”. 

 


About us:

Breast Cancer Network Australia (BCNA) is Australia’s leading breast cancer consumer organisation. BCNA provides information and support to those diagnosed and their supporters, opportunities to connect with others going through a similar situation and work to influence a stronger healthcare system to ensure all Australians affected by breast cancer receive the very best care, treatment and support.


Contact details:

 

BCNA Media & Communications Team

03 9805 2540

media@bcna.org.au

More from this category

  • Medical Health Aged Care, Research Development
  • 17/02/2025
  • 15:07
Australia New Zealand Gynaecological Oncology Group (ANZGOG)

ANZGOG Announces Keynote Speaker for 2025 Annual Scientific Meeting: A/Professor Carien Creutzberg

The Australia New ZealandGynaecological Oncology Group (ANZGOG) is pleased to welcome internationally renowned Radiation Oncologist Professor Carien Creutzberg as a keynote speaker at the…

  • Contains:
  • Medical Health Aged Care
  • 17/02/2025
  • 11:51
Monash University

Monash Expert: Landmark approval of weight loss drug for heart disease

For the first time in Australia, a weight loss drug has been approved to also treat cardiovascular disease in overweight and obese patients. The Therapeutic Goods Administration (TGA) has granted approval for semaglutide 2.4 mg (sold as Wegovy) to be used as a complementary therapy for reducing major adverse cardiovascular events such as cardiovascular death, non-fatal myocardial infarction (heart attack), or non-fatal stroke. The approval follows findings from the SELECT trial, an international study involving more than 17,000 participants across 41 countries, including Australia. Results published in late 2023 showed that Wegovy reduced cardiovascular events by 20 percent in people…

  • Medical Health Aged Care
  • 17/02/2025
  • 10:11
Smith & Nephew UK Ltd

Smith+Nephew steps forward with innovative Sports Medicine foot & ankle repair solutions in Australia and New Zealand

First in market to offer Adjustable Tensioning Technology* for insertional Achilles reconstruction and lateral ankle instability repair*After anchor insertionSmith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of a comprehensive foot & ankle repair portfolio in Australia and New Zealand (ANZ) with proprietary adjustable tensioning technology. The ULTRABRIDGE◊ Adjustable Achilles Reconstruction and ULTRABRACE◊ Adjustable Ankle Instability Techniques are changing the way foot & ankle surgeons perform these repairs by allowing them to refine and optimise suture tension after anchor insertion.The ability to adjust tension for specific patients allows the surgeon to give the precise amount of range-of-motion…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.